NCT02359344View on ClinicalTrials.gov

PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 3, 2015

Primary Completion Date

April 20, 2015

Study Completion Date

April 20, 2015

Conditions
Trigeminal Neuralgia
Interventions
DRUG

CNV1014802

DRUG

Placebo

Trial Locations (1)

Unknown

Parexel International, London

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY